Dental Pain – Pipeline Review, H2 2019

“Global Markets Direct’s, ‘Dental Pain – Pipeline Review, H2 2019’, provides an overview of the Dental Pain pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Dental Pain, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Dental Pain and features dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.”

Scope


– The report provides a snapshot of the global therapeutic landscape of Dental Pain

– The report reviews pipeline therapeutics for Dental Pain by companies and universities/research institutes based on information derived from company and industry-specific sources

– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

– The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

– The report reviews key players involved Dental Pain therapeutics and enlists all their major and minor projects

– The report assesses Dental Pain therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

– The report summarizes all the dormant and discontinued pipeline projects

– The report reviews latest news related to pipeline therapeutics for Dental Pain”

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of therapeutics under development for Dental Pain

- Identify potential new clients or partners in the target demographic

- Develop strategic initiatives by understanding the focus areas of leading companies

- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

- Devise corrective measures for pipeline projects by understanding Dental Pain pipeline depth and focus of Indication therapeutics

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Companies mentioned

“AfaSci Inc

Esteve Pharmaceuticals SA

Grunenthal GmbH

Nevakar Inc

Pacira BioSciences Inc

Promius Pharma LLC”

Table of Contents

Table of Contents

List of Tables

List of Figures

Introduction

Global Markets Direct Report Coverage

Dental Pain Overview

Dental Pain Therapeutics Development

Pipeline Overview

Pipeline by Companies

Products under Development by Companies

Dental Pain Therapeutics Assessment

Assessment by Target

Assessment by Mechanism of Action

Assessment by Route of Administration

Assessment by Molecule Type

Dental Pain Companies Involved in Therapeutics Development

Laboratorios Del Dr Esteve SA

Pacira Pharmaceuticals Inc

Teva Pharmaceutical Industries Ltd

Dental Pain Drug Profiles

(celecoxib + tramadol hydrochloride) Drug Profile

Product Description

Mechanism Of Action

R&D Progress

A-100 Drug Profile

Product Description

Mechanism Of Action

R&D Progress

AFAP-3 Drug Profile

Product Description

Mechanism Of Action

R&D Progress

bupivacaine ER Drug Profile

Product Description

Mechanism Of Action

R&D Progress

funapide Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Dental Pain Dormant Projects

Dental Pain Discontinued Products

Dental Pain Product Development Milestones

Featured News & Press Releases

Jun 21, 2012: Iroko Pharma Announces Phase III Study Results Of Diclofenac

Nov 04, 2011: Phase II Results For Nano-formulated NSAIDs Under Development At Iroko Pharmaceuticals To Be Reported At ACR Meeting

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

“List of Tables

Number of Products under Development for Dental Pain (Toothache/Tooth Pain), H2 2019

Number of Products under Development by Companies, H2 2019

Products under Development by Companies, H2 2019

Number of Products by Stage and Target, H2 2019

Number of Products by Stage and Mechanism of Action, H2 2019

Number of Products by Stage and Route of Administration, H2 2019

Number of Products by Stage and Molecule Type, H2 2019

Dental Pain (Toothache/Tooth Pain) – Pipeline by AfaSci Inc, H2 2019

Dental Pain (Toothache/Tooth Pain) – Pipeline by Esteve Pharmaceuticals SA, H2 2019

Dental Pain (Toothache/Tooth Pain) – Pipeline by Grunenthal GmbH, H2 2019

Dental Pain (Toothache/Tooth Pain) – Pipeline by Nevakar Inc, H2 2019

Dental Pain (Toothache/Tooth Pain) – Pipeline by Pacira BioSciences Inc, H2 2019

Dental Pain (Toothache/Tooth Pain) – Pipeline by Promius Pharma LLC, H2 2019

Dental Pain (Toothache/Tooth Pain) – Dormant Projects, H2 2019

Dental Pain (Toothache/Tooth Pain) – Dormant Projects, H2 2019 (Contd..1), H2 2019

Dental Pain (Toothache/Tooth Pain) – Discontinued Products, H2 2019”

List of Figures

“List of Figures

Number of Products under Development for Dental Pain (Toothache/Tooth Pain), H2 2019

Number of Products under Development by Companies, H2 2019

Number of Products by Top 10 Targets, H2 2019

Number of Products by Stage and Top 10 Targets, H2 2019

Number of Products by Top 10 Mechanism of Actions, H2 2019

Number of Products by Stage and Top 10 Mechanism of Actions, H2 2019

Number of Products by Routes of Administration, H2 2019

Number of Products by Stage and Routes of Administration, H2 2019

Number of Products by Molecule Types, H2 2019

Number of Products by Stage and Molecule Types, H2 2019”

    Pricing

Discounts available for multiple report purchases.

reportstore@globalmarketsdirect.com
+44 (0) 161 359 5414

Saved reports